Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 92 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry)Brilakis, E.S.; Banerjee, S.; Karmpaliotis, D.; Lombardi, W.L.; Tsai, T.T.; Shunk, K.A.; Kennedy, K.F.; Spertus, J.A.; Holmes, D.R.; Grantham, J.A.
2013Aortic stiffness in lone atrial fibrillation: A novel risk factor for arrhythmia recurrenceLau, D.; Middeldorp, M.; Brooks, A.; Ganesan, A.; Roberts-Thomson, K.; Stiles, M.; Leong, D.; Abed, H.; Lim, H.; Wong, C.; Willoughby, S.; Young, G.; Kalman, J.; Abhayaratna, W.; Sanders, P.; Calvert, J.
2011Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancerDeenen, M.; Tol, J.; Burylo, A.; Doodeman, V.; de Boer, A.; Vincent, A.; Guchelaar, H.; Smits, P.; Beijnen, J.; Punt, C.; Schellens, J.; Cats, A.
2013Primary treatment results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, IndonesiaWildeman, M.; Fles, R.; Herdini, C.; Indrasari, R.; Vincent, A.; Tjokronagoro, M.; Stoker, S.; Kurnianda, J.; Karakullukcu, B.; Taroeno-Hariadi, K.; Hamming-Vrieze, O.; Middeldorp, J.; Hariwiyanto, B.; Haryana, S.; Tan, I.; Tse, W.
2013Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, mutlicentre, randomised phase 3 studyBuikhuisen, W.; Burgers, J.; Vincent, A.; Korse, C.; van Klaveren, R.; Schramel, F.; Pavlakis, N.; Nowak, A.; Custers, F.; Schouwink, J.; Gans, S.; Groen, H.; Strankinga, W.; Baas, P.
2013Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomesCho, Y.; Badve, S.; Hawley, C.; McDonald, S.; Brown, F.; Boudville, N.; Bannister, K.; Clayton, P.; Johnson, D.
2013Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trialVermorken, J.; Stohlmacher-Williams, J.; Davidenko, I.; Licitra, L.; Winquist, E.; Villanueva, C.; Foa, P.; Rottey, S.; SkladowskI, K.; Tahara, M.; Pai, V.; Faivre, S.; Blajman, C.; Forastiere, A.; Stein, B.; Oliner, K.; Pan, Z.; Bach, B.
2013Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapyAngelini, S.; Soverini, S.; Ravegnini, G.; Barnett, M.; Turrini, E.; Thornquist, M.; Pane, F.; Hughes, T.; White, D.; Radich, J.; Kim, D.; Saglio, G.; Cilloni, D.; Iacobucci, I.; Perini, G.; Woodman, R.; Cantelli-Forti, G.; Baccarani, M.; Hrelia, P.; Martinelli, G.
2013Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation a randomized clinical trialAbed, H.; Wittert, G.; Leong, D.; Shirazi, M.; Bahrami, B.; Middeldorp, M.; Lorimer, M.; Lau, D.; Antic, N.; Brooks, A.; Abhayaratna, W.; Kalman, J.; Sanders, P.
2013Pharmacovigilance in hospice/palliative care: net effect of haloperidol for deliriumCrawford, G.; Agar, M.; Quinn, S.; Phillips, J.; Litster, C.; Michael, N.; Doogue, M.; Rowett, D.; Currow, D.